Skip to content

Clinical trials

Observational Diabetes Mellitus trials in the United Arab Emirates

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus Phase: Observational Country / region: United Arab Emirates Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20112
20131
20141
20151
20171
20182
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Imperial College London Diabetes Centre3
Novo Nordisk A/S2
Bayer1
Eli Lilly and Company1
Liwa College1
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.1
Sanofi1
United Arab Emirates University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus11
Diabetes Mellitus, Type 15
Diabetes Mellitus, Type 25
Obesity2
Burnout, Professional1
Diabetic Retinopathy1
Disease Progression1
Dyslipidemias1
Hypertension1
Hypoglycemia1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.